Prophylaxis of cytomegalovirus infection in bone marrow transplant patients

This publication has 21 references indexed in Scilit:

• Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation
  The Lancet, 1994
• Cytomegalovirus (CMV)-Specific Intravenous Immunoglobulin for the Prevention of Primary CMV Infection and Disease after Marrow Transplant
  The Journal of Infectious Diseases, 1991
• GANCICLOVIR/IMMUNOGLOBULIN COMBINATION THERAPY FOR THE TREATMENT OF HUMAN CYTOMEGALOVIRUS-ASSOCIATED INTERSTITIAL PNEUMONIA IN BONE MARROW ALLOGRAFT RECIPIENTS
  Transplantation, 1988
• Treatment of Cytomegalovirus Pneumonia with Ganciclovir and Intravenous Cytomegalovirus Immunoglobulin in Patients with Bone Marrow Transplants
  Annals of Internal Medicine, 1988
• Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow Transplantation
  New England Journal of Medicine, 1988
• Treatment of Cytomegalovirus Pneumonia with 9-[2-Hydroxy-1-(Hydroxymethyl) ethoxymethyl] Guanine and High-Dose Corticosteroids
  Annals of Internal Medicine, 1986
• Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow Transplantation
  New England Journal of Medicine, 1986
• Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease
  Blood, 1986
• Risk Factors for Cytomegalovirus Infection after Human Marrow Transplantation
  The Journal of Infectious Diseases, 1986
• PROPHYLAXIS OF HERPES INFECTIONS AFTER BONE-MARROW TRANSPLANTATION BY ORAL ACYCLOVIR
  The Lancet, 1983